The Food and Drug Monitoring Agency (BPOM) has approved phase 3 clinical trials for the M72 tuberculosis (TB) vaccine, aiming to assess its efficacy amid the country's high TB burden.
Minister of Health Budi Gunadi Sadikin has confirmed that the Bill Gates Foundation-supported .M72 tuberculosis (TB) vaccine candidate is safe, as it has passed the first phase of clinical trials and is now in the third phase to evaluate its effectiveness. Learn more.
The Ministry of Health is prioritizing the Mpox vaccine for specific groups, particularly those with HIV, while encouraging good hygiene to prevent outbreaks. Read more about the efforts.
